We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Corporate

  • May 3, 2011

    2nd Circ. Denies Bail Bid In Goldman Code Theft Case

    The Second Circuit on Tuesday denied a former Goldman Sachs Group Inc. programmer's request to be released from jail pending his appeal of a conviction on charges associated with stealing the investment bank's trading system code.

  • May 3, 2011

    Senate Probes Medtronic Decision To Nix GPO Contracts

    A U.S. Senate committee launched an investigation Monday into medical device giant Medtronic Inc.'s recent decision to cancel contracts with a major group-purchasing organization, noting concerns over increased costs for hospitals, Medicare and Medicaid.

  • May 3, 2011

    BP Agrees To $85M Settlement In Alaska Spill Suit

    Federal environmental regulators said Tuesday that a BP PLC subsidiary will pay a $25 million civil penalty and spend $60 million on safety upgrades to resolve litigation over pipeline spills that dumped more than 5,000 barrels of oil on Alaska's North Slope in 2006.

  • May 3, 2011

    ICG Ordered To Pay $104M Over Coal Supply Contract

    International Coal Group Inc. said Tuesday it had been hit with a roughly $104 million judgment in Pennsylvania over a breached coal supply contract, a ruling issued the same day Arch Coal Inc. announced it was buying ICG for $3.4 billion.

  • May 2, 2011

    Nasdaq, ICE Bid For NYSE Goes Hostile

    Nasdaq OMX Group Inc. and IntercontinentalExchange Inc. said Monday they would take their $11 billion bid for rival NYSE Euronext Inc. hostile, adding another wrinkle to a deal that has already drawn scrutiny from antitrust regulators.

  • May 2, 2011

    Juror's Health Impedes Rajaratnam Deliberations

    A federal judge in New York on Monday agreed to suspend jury deliberations for a day in the insider trading trial of Raj Rajaratnam in order to accommodate a juror's unspecified medical issues.

  • May 2, 2011

    NHTSA Pulls 288K Honda SUVs Into Safety Probe

    The National Highway Traffic Safety Administration launched a probe into 288,000 American Honda Motor Co. Inc. SUVs on Friday, just days after kicking off investigations into more than a million SUVs manufactured by Michigan-based General Motors Co. and Ford Motor Co.

  • May 2, 2011

    Grifols, FTC Ink Deal To Allow $3.4B Talecris Tie-Up

    Grifols SA said Monday it had reached a tentative agreement with federal antitrust regulators that should allow its planned $3.4 billion purchase of rival Talecris Biotherapeutics Holdings Corp. to move forward once certain blood plasma assets are sold off.

  • May 2, 2011

    Dish, EchoStar Settle TiVo DVR Patent Suit For $500M

    Dish Network Corp. and EchoStar Corp. said Monday they had reached a $500 million settlement with TiVo Inc. in long-running litigation over a digital video recorder patent, in the wake of an April appeals court ruling largely siding with TiVo.

  • May 2, 2011

    Supreme Court Denies Mo. Flood Control Injunction

    A U.S. Supreme Court justice on Sunday denied Missouri's injunction bid to stop a U.S. Army Corps of Engineers levee detonation that would protect an Illinois town from Mississippi River floodwater but flood 130,000 acres in Missouri.

  • April 29, 2011

    NFL Lockout Can Resume Pending Appeal: 8th Circ.

    The National Football League's player lockout is back on after the Eighth Circuit on Friday granted the league's request for a temporary stay of a district court's preliminary injunction in an antitrust class action brought by a group of players.

  • April 29, 2011

    Actelion Must Pay Asahi $550M In Fasudil Suit: Jury

    Actelion Ltd. on Friday was ordered by a California state court jury to pay Asahi Kasei Pharma Corp. $550 million in damages for interrupting an Asahi licensing agreement to develop hypertension drug Fasudil after acquiring CoTherix Inc. in 2007.

  • April 29, 2011

    Big Tobacco Wins $455M Fight Against Mo. Hospitals

    A St. Louis jury found Friday that Lorillard Inc. and five other tobacco giants were not responsible for $455 million in costs that 37 Missouri hospitals claimed they incurred from treating charity and bad-debt patients who were smokers.

  • April 29, 2011

    Lilly, SEC Push Toward Deal In FCPA Probe

    Drug and medical device maker Eli Lilly & Co. said Friday it was in advanced discussions with the U.S. Securities and Exchange Commission to resolve an investigation into potential violations of the Foreign Corrupt Practices Act.

  • April 29, 2011

    DC Circ. OKs Funding For Embryonic Stem Cell Research

    The District of Columbia Circuit on Friday overturned a preliminary injunction barring the National Institutes of Health from funding research using human embryonic stem cells, giving the Obama administration a boost as it continues to litigate the landmark case.

  • April 29, 2011

    EU Opens Antitrust Probes Into Major Banks Over CDS

    The European Union's antitrust watchdog on Friday unveiled two probes into the credit default swaps market, targeting 16 top investment banks including JPMorgan Chase & Co., Goldman Sachs Group Inc. and Bank of America Corp.

  • April 28, 2011

    Allergan Hit With $212M Verdict In Botox Suit

    Allergan Inc. on Thursday was ordered by a federal jury in Virginia to pay $212 million to a man who suffered brain damage after treating a tremor and cramp in his right hand with the company's Botox drug.

  • April 28, 2011

    US Seeks To Curb Kids' Exposure To Unhealthy Food Ads

    The U.S. government on Thursday revealed voluntary principles aimed at improving the nutritional profile of foods marketed to children, in an effort to help curb the high rate of childhood obesity.

  • April 28, 2011

    Horizon Avoids Ch. 11 After Judge Cuts $45M Antitrust Fine

    A Puerto Rico federal judge on Thursday reduced a criminal price-fixing fine against Horizon Lines LLC from $45 million to $15 million, preventing the company from defaulting on a loan and possibly having to file for bankruptcy.

  • April 28, 2011

    EU Probes Cephalon, Teva Deal Over Generic Provigil

    The European Union's antitrust watchdog said Thursday it had launched a formal probe of U.S. pharmaceutical giant Cephalon Inc.’s alleged attempt to pay Teva Pharmaceutical Industries Ltd. to keep a generic version of narcolepsy drug Provigil off the market.